Frontiers in Medicine | |
The Impact of COVID-19 Pandemic on Clinical Research in China: Challenges and Progress | |
article | |
Yuan Yang1  Wen Li1  Ling Zhang3  Qinge Zhang3  Teris Cheung4  Brian J. Hall5  Yu-Tao Xiang1  | |
[1] Faculty of Health Sciences, Institute of Translational Medicine, University of Macau;Southern Medical University Nanfang Hospital;The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital & The Advanced Innovation Center for Human Brain Protection, Capital Medical University;School of Nursing, Hong Kong Polytechnic University;New York University (Shanghai) | |
关键词: COVID-19; China; clinical; research; progress; | |
DOI : 10.3389/fmed.2020.00523 | |
学科分类:社会科学、人文和艺术(综合) | |
来源: Frontiers | |
【 摘 要 】
The Novel Coronavirus Disease 2019 (COVID-19 hereafter) was first reported in Wuhan, Hubei province, China at the end of 2019, and then was found in more than 200 countries worldwide. As of April 2020, the COVID-19 outbreak has been well-contained in China. It is beyond doubt that the COVID-19 outbreak has greatly transformed clinical research in China, and this transformation is of interest to the international community. Hence, we believe that a balanced and comprehensive overview describing the impact of COVID-19 on clinical research, the challenges researchers are facing, and an update on the progress of clinical research in China is warranted.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202108180001870ZK.pdf | 113KB | download |